Skip to Content

Q150 (Quetiapine Fumarate Extended-Release 150 mg)

Pill with imprint Q150 is White, Capsule-shape and has been identified as Quetiapine Fumarate Extended-Release 150 mg. It is supplied by Mallinckrodt Inc..

Quetiapine is used in the treatment of bipolar disorder; schizoaffective disorder; generalized anxiety disorder; depression; schizophrenia (and more), and belongs to the drug class atypical antipsychotics. Risk cannot be ruled out during pregnancy. Quetiapine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for Q150

Quetiapine Fumarate Extended-Release

Imprint:
Q150
Strength:
150 mg
Color:
White
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Atypical antipsychotics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Mallinckrodt Inc.
National Drug Code (NDC):
00406-1181

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide